Trial Profile
Etude prospective, multicentrique, de phase II testant la faisabilite dun traitement dentretien par lalemtuzumab chez des patients porteurs de leucemie lymphoide chronique, traites et repondant a lalemtuzumab.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2012
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Acronyms Campath-LLC-entretien
- 06 Aug 2011 New trial record